Revenue: The sum of all revenue fields included for a company's operating activities.
Clovis Oncology, Inc. (CLVSQ) had Revenue of $30.66M for the most recently reported fiscal quarter, ending 2022-09-30.
| Income Statement Financials | |
|
Revenue |
$30.66M |
$-56.01M |
|
$8.61M |
|
$22.05M |
|
$74.90M |
|
$-44.23M |
|
$-11.74M |
|
$-55.98M |
|
$-55.98M |
|
$-56.01M |
|
$-56.01M |
|
$-56.01M |
|
$-56.01M |
|
$-44.23M |
|
$-41.78M |
|
144.62M |
|
144.62M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$102.21M |
|
$4.85M |
|
$244.57M |
|
$346.77M |
|
$747.87M |
|
-- |
|
$16.79M |
|
$764.66M |
|
$-417.89M |
|
$-537.30M |
|
$-417.89M |
|
144.80M |
|
| Cash Flow Statement Financials | |
$-134.23M |
|
$-0.20M |
|
$53.18M |
|
$143.43M |
|
$58.32M |
|
$-85.11M |
|
$16.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-- |
|
-1.05 |
|
71.93% |
|
-144.26% |
|
-144.26% |
|
-- |
|
-182.56% |
|
-182.68% |
|
$-134.43M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.75 |
|
1.58 |
|
57.10 |
|
13.40% |
|
10.43% |
|
-16.15% |
|
13.40% |
|
$-2.89 |
|
$-0.93 |
|
$-0.93 |
|